Drug Impurity Analysis

Drug Impurity Analysis is a toxicological screening methodology that identifies and quantifies unintended chemical constituents in pharmaceutical substances, distinguishing itself by its focus on assessing the safety, origin, and structural characteristics of impurities arising during synthesis, degradation, or formulation.

550

Publications

15.6K

Citations

2.1K

Authors

509

Institutions

Publications per year

2017–2026

119

Authors

2.1K

  1. SG
    Sándor Gǒrög

    Gedeon Richter (Hungary), Hungary

    13 publications · 585 citations

    13

    h-index

  2. KV
    K. Vyas

    Dr. Reddy's Laboratories (India), India

    9 publications · 236 citations

    9

    h-index

  3. JM
    J. Moses Babu

    Dr. Reddy's Laboratories (India), India

    9 publications · 236 citations

    9

    h-index

  4. BA
    Bernard A. Olsen

    Eli Lilly (United States), United States

    7 publications · 343 citations

    7

    h-index

  5. YV
    Yvan Vander Heyden

    Vrije Universiteit Brussel, Belgium

    7 publications · 179 citations

    7

    h-index

1–5 of 2.1K

Venues

  1. Journal of Pharmaceutical and Biomedical Analysis

    149 publications · 3.6K citations

    31

    h-index

  2. Journal of Chromatography A

    44 publications · 1.6K citations

    24

    h-index

  3. Forensic Science International

    28 publications · 894 citations

    20

    h-index

  4. Chromatographia

    17 publications · 364 citations

    14

    h-index

  5. Organic Process Research & Development

    19 publications · 576 citations

    13

    h-index

1–5